Cannabics Pharmaceuticals Inc. Stock Price - CNBX

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
SMALL CAP PRO
Monthly Subscription
for only
$43.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$49.99
VAT not included
After Hours
Last Trade
Last: $ 2.09 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Cannabics Pharmaceuticals Inc. (QB) CNBX Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.11 -5.00% 2.09 2.24 2.03 2.24 2.20 15:59:47
Bid Price Ask Price Spread Spread % News
2.06 2.09 0.03 1.44% 1 -
Stock Trades Traded Volume Average Volume 52 Week Range
513 284,264 1.33M 0.02 - 7.60
Last Trade Time Type Quantity Stock Price Currency
16:03:32 67 $2.06 USD

Cannabics Pharmaceuticals Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 240.68M 115.16M $ -307.18k - -783.50 14.3M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
486.68k 0.42% $ - 0.00% - -

more financials information »

Cannabics Pharmaceuticals Inc. (QB) News

Historical CNBX Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week2.322.351.990.0000118k560k316k-0.23-9.91%
1 Month2.953.2051.950.0000118k1M438k-0.86-29.15%
3 Months0.740057.600.730.0000118k11M1M1.34995182.41%
6 Months0.187.600.1750.0000118k11M1M1.911,061.11%
1 Year0.079087.600.02250.0000011M567k2.010922,542.89%
3 Years0.167.600.0210.0000011M205k1.931,206.25%
5 Years0.077.600.0210.0000011M196k2.022,885.71%

Cannabics Pharmaceuticals Inc. (QB) Description

Cannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer treatments. The Company's scientific focus is on harnessing the proven therapeutic properties of natural Cannabinoids. Cannabics' vision is to create tailored therapies for cancer patients, utilizing advanced HTS technology and personalized bioinformatics tools. The Company's R&D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and academic research as well as current ongoing medical clinical studies which are registered with the US NIH. Cannabics Pharmaceuticals is dedicated to the development of advanced cannabinoid-based treatments and therapies. The Company's main focus is the development of novel therapies and biotechnological tools aimed to providing relief from diverse ailments and treat human malignancies. These advanced tools include novel delivery systems, personalized medicine diagnostics and therapies based on cannabinoid compounds. Cannabics' research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on cutting edge High Through-output Screening and bioinformatic tools.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.